Underutilization of BRCA1/2 testing to guide breast cancer treatment: Black and Hispanic women particularly at risk
暂无分享,去创建一个
Douglas E Levy | William H Crown | Judy E Garber | J. Garber | D. Levy | W. Crown | S. Syngal | Sapna Syngal | Alexandra E Shields | Stacey D Byfield | Catherine B Comstock | Alexandra E. Shields | S. Byfield | C. Comstock
[1] Katrina Armstrong,et al. Interest in BRCA1/2 testing in a primary care population. , 2002, Preventive medicine.
[2] O. Olopade,et al. Confronting genetic testing disparities: knowledge is power. , 2005, JAMA.
[3] James P Evans,et al. Increased uptake of BRCA1/2 genetic testing among African American women with a recent diagnosis of breast cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] B. Rimer,et al. Triangulating Differential Nonresponse by Race in a Telephone Survey , 2007, Preventing chronic disease.
[5] R. Croyle,et al. Awareness of Genetic Testing for Increased Cancer Risk in the Year 2000 National Health Interview Survey , 2004, Public Health Genomics.
[6] M. Cabana,et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. , 1999, JAMA.
[7] M. Skolnick,et al. Statement of the American Society of Clinical Oncology : Genetic testing for cancer susceptibility. Commentaries , 1996 .
[8] A. Jha,et al. Concentration and quality of hospitals that care for elderly black patients. , 2007, Archives of internal medicine.
[9] J. Coyne,et al. Factors associated with decisions about clinical BRCA1/2 testing. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[10] C. Isaacs,et al. Utilization of BRCA1/BRCA2 Mutation Testing in Newly Diagnosed Breast Cancer Patients , 2005, Cancer Epidemiology Biomarkers & Prevention.
[11] K. Armstrong,et al. The association between race and attitudes about predictive genetic testing. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[12] J. Herman. Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities. , 2010, Obstetrics and gynecology.
[13] U. P. S. T. Force. Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Recommendation Statement , 2005, Annals of Internal Medicine.
[14] Ellen Warner,et al. Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] F. Collins,et al. Genetics moves into the medical mainstream. , 2001, JAMA.
[16] Bernard Challenor,et al. Bad Blood: The Tuskegee Syphilis Experiment , 1982 .
[17] M. Putt,et al. Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. , 2005, JAMA.
[18] S. Merajver,et al. Health insurance and discrimination concerns and BRCA1/2 testing in a clinic population. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[19] L. Wideroff,et al. The Impact of Acculturation on Awareness of Genetic Testing for Increased Cancer Risk among Hispanics in the Year 2000 National Health Interview Survey , 2006, Cancer Epidemiology Biomarkers & Prevention.
[20] R. Hasnain-Wynia,et al. Disparities in health care are driven by where minority patients seek care: examination of the hospital quality alliance measures. , 2007, Archives of internal medicine.
[21] E. Rosenthal. Shortage of Genetics Counselors May be Anecdotal, but Need is Real , 2007 .
[22] Deborah Schrag,et al. Primary care physicians who treat blacks and whites. , 2004, The New England journal of medicine.
[23] T. Rebbeck,et al. Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] K. Offit,et al. Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[25] C. Isaacs,et al. Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk. , 1997, Patient education and counseling.
[26] T. Eberlein. Hospital Factors and Racial Disparities in Mortality After Surgery for Breast and Colon Cancer , 2011 .
[27] James H. Jones. Bad Blood: The Tuskegee Syphilis Experiment , 1981 .
[28] J. Garber,et al. Guidelines for Genetic Risk Assessment of Hereditary Breast and Ovarian Cancer: Early Disagreements and Low Utilization , 2009, Journal of General Internal Medicine.
[29] Ahmedin Jemal,et al. Cancer Disparities by Race/Ethnicity and Socioeconomic Status , 2004, CA: a cancer journal for clinicians.
[30] S. Neuhausen,et al. Prevalence of BRCA Mutations and Founder Effect in High-Risk Hispanic Families , 2005, Cancer Epidemiology Biomarkers & Prevention.
[31] Colorectal cancer screening. , 1991, Journal of the National Cancer Institute.
[32] Adopted on March. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] D. Levy,et al. Differential use of available genetic tests among primary care physicians in the United States: results of a national survey , 2008, Genetics in Medicine.
[34] A. Hendricks,et al. Measuring quality of care: fundamental information from administrative datasets. , 1994, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[35] M. Cho,et al. How Do Women Decide? Accepting or Declining BRCA1/2 Testing in a Nationwide Clinical Sample in the United States , 2006, Public Health Genomics.
[36] Sean V Tavtigian,et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] B. Ward,et al. BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast‐ovarian cancer , 2009, Cancer.